ELIZABETH FAIRLEY

Chief Operating Officer, Talking Medicines

Elizabeth Fairley joined Talking Medicines in 2016 as a Founder. Her role as COO is to lead on the development and commercialisation of the patient-centric data platform, PatientMetRx®, as well as raising awareness and investment for the Company.

Elizabeth has founded numerous enterprises including running her own life science consultancy business for over 10 years. She has international experience of launching and scaling businesses. In 2014, Elizabeth graduated as a Saltire Fellow after completing a world-class, 8-month entrepreneurial business leadership programme (accelerated MBA) led with Babson College, Boston. Elizabeth has a Ph.D. in Biology from the University of Cambridge and BSc (Hons) in Genetics from the University of Aberdeen.

With a keen interest in the development and use of predictive health to transform the diagnosis, treatment and management of care for the individual, Elizabeth is passionate about making a difference.